Health Care • Medical/Dental Instruments
$2.24 ▼ -0.07
(-3.03%)
MKT CAP: $12.2M • VOL: 81.7K
52W L $2 52W H $6
ROARABLE / RQD
E • 31/100
PIOTROSKI
4 / 9
ICU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.2M | $135.0K | $0 |
| YoY Revenue Growth % | +814.1% | — | — |
| Gross Profit | $1.2M | $135.0K | — |
| Gross Margin % | 95.7% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.2M | -$17.8M | -$14.2M |
| Operating Margin % | -80.0% | -80.0% | — |
| Net Income (GAAP) | -$12.2M | -$24.8M | -$26.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.6M | -$16.0M | -$10.3M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$13.6M | -$16.0M | -$10.3M |
| FCF Margin % | -80.0% | -80.0% | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $10.4M | -$2.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ICU.